Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Rapid Dose Therapeutics Corp. (DOSE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1150+0.0150 (+15.00%)
At close: 12:37PM EDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1000
Open0.0000
Bid0.1100 x 0
Ask0.1150 x 0
Day's Range0.1000 - 0.1000
52 Week Range0.0800 - 0.6900
Volume5,505
Avg. Volume31,033
Market Cap11.93M
Beta (5Y Monthly)1.74
PE Ratio (TTM)N/A
EPS (TTM)-0.0230
Earnings DateJan 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for DOSE.CN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

      BURLINGTON, Ontario, July 28, 2022--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

    • Business Wire

      Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order

      BURLINGTON, Ontario, June 30, 2022--Rapid Dose Therapeutics Corp. ("RDT"), (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that, further to its press release dated June 16, 2022 (the "Default Announcement"), at the request of the Company, the Ontario Securities Commission (the "OSC") has issued a management cease trade order (the "MCTO") pursuant to National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").

    • Business Wire

      Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

      BURLINGTON, Ontario, June 16, 2022--Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements

    Advertisement
    Advertisement